Incyte Corp (INCY)
60.60
-0.08
(-0.13%)
USD |
NASDAQ |
Mar 28, 16:00
60.32
-0.28
(-0.46%)
After-Hours: 07:13
Incyte Profit Margin (Quarterly): 17.07% for Dec. 31, 2024
View 4,000+ Financial Data Types:
Add
Browse
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Eli Lilly and Co | 32.59% |
| Gilead Sciences Inc | 23.56% |
| Syndax Pharmaceuticals Inc | -1.23K% |
| Halozyme Therapeutics Inc | 45.98% |
| Regeneron Pharmaceuticals Inc | 24.22% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 0.81% |
| Return on Assets | 0.56% |
| Return on Invested Capital | 0.81% |
| Gross Profit Margin (Quarterly) | 92.49% |
| Operating Margin (Quarterly) | 25.23% |
| Return on Net Operating Assets | 1.72% |